Pentacyclic triterpenes from the fungus, Leptosphaeria maculans
摘要:
Fermented broth of the fungus, Leptosphaeria maculans gave two pentacyclic triterpenoid compounds. Based on spectral analysis these compounds were identified as maculaniol and 3-alpha-hydroxy-urs-18,20-dien-28-oic acid.
Active fraction of a polar solvent extract from the latex of euphorbiaceae plants
申请人:AMAZONIA FITOMEDICAMENTOS LTDA.
公开号:US10143673B2
公开(公告)日:2018-12-04
The present invention generally refers to an active fraction of an extract of the latex of plants from the family Euphorbiaceae in a polar solvent, as well as of one or more compounds contained therein, as well as the use of said fraction and/or said compounds, particularly in the treatment of cancer. The invention also refers to compositions comprising said active fraction and/or said compounds, as well as their use for the treatment of diseases concerning cell proliferation/angiogenesis, particularly cancer.
ACTIVE FRACTION OF A POLAR SOLVENT EXTRACT FROM THE LATEX OF EUPHORBIACEAE PLANTS
申请人:Amazônia Fitomedicamentos Ltda.
公开号:EP1901758B1
公开(公告)日:2013-05-01
[EN] ACTIVE FRACTION OF A POLAR SOLVENT EXTRACT FROM THE LATEX OF EUPHORBIACEAE PLANTS<br/>[FR] FRACTION ACTIVE D'EXTRAITS PAR SOLVANT POLAIRE DU LATEX D'EUPHORBIACEAE
申请人:AMAZONIA FITOMEDICAMENTOS LTDA
公开号:WO2007000618A1
公开(公告)日:2007-01-04
[EN] The present invention generally refers to an active fraction of an extract of the latex of plants from the family Euphorbiaceae in a polar solvent, as well as of one or more compounds contained therein, as well as the use of said fraction and/or said compounds, particularly in the treatment of cancer. The invention also refers to compositions comprising said active fraction and/or said compounds, as well as their use for the treatment of diseases concerning cell proliferation/angiogenesis, particularly cancer. [FR] L'invention porte sur la fraction active d'extraits par solvant polaire du latex de plante de la famille Euphorbiaceae, ainsi que sur un ou plusieurs composés y étant contenus et sur l'utilisation de ladite fraction et/ou desdits composés en en particulier pour le traitement du cancer. L'invention porte également sur des compositions comprenant ladite fraction active et/ou lesdits composés, et sur leur utilisation pour le traitement de maladies liées à la prolifération cellulaire et à l'angiogenèse, et en particulier du cancer.